AI assistant
Sending…
PLUS THERAPEUTICS, INC. — Director's Dealing 2013
Sep 11, 2013
34301_dirs_2013-09-11_de781a2f-82b7-4132-b967-eda44efce6c9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2013-09-10
Reporting Person: RICKEY DAVID (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-09-10 | Common Stock | P | 1000 | $2.6199 | Acquired | 191976 | Indirect |
| 2013-09-11 | Common Stock | P | 1000 | $2.54 | Acquired | 192976 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 111559 | Indirect |
| Common Stock | 34909 | Indirect |
| Restricted Stock Award (Common Stock) | 6100 | Direct |
Footnotes
F1: These securities are owned by Dave Rickey, TTEE FBO the David Rickey Trust
More from PLUS THERAPEUTICS, INC.
Capital/Financing Update
2026
Jun 5
Regulatory Filings
2026
Jun 5
Capital/Financing Update
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
Apr 21
Board/Management Information
2026
Apr 9
Regulatory Filings
2026
Apr 8
Board/Management Information
2026
Mar 26